# reload+after+2024-01-23 14:44:24.600606
address1§12340 El Camino Real
city§San Diego
state§CA
zip§92130
country§United States
phone§858 450 4222
fax§858 200 3877
website§https://www.dermtech.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.
fullTimeEmployees§278
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Kevin  Sun M.B.A.', 'age': 45, 'title': 'CFO, Treasurer & Secretary', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 461921, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Claudia  Ibarra', 'age': 61, 'title': 'Chief Operating Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 414087, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ray  Akhavan Esq., J.D.', 'age': 54, 'title': 'General Counsel', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 413055, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bret  Christensen', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. William W. Zondler', 'title': 'Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Steve E. Kunszabo', 'title': 'Senior Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Eilemberg', 'title': 'Chief Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ray  Bassi', 'title': 'Vice President of Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Burkhard  Jansen M.D.', 'age': 57, 'title': 'Chief Medical Affairs Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 419796, 'exercisedValue': 0, 'unexercisedValue': 115992}, {'maxAge': 1, 'name': 'Mr. Daniel  Visage', 'title': 'Senior Vice President of Payer Access', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§5
compensationRisk§7
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.652
priceToSalesTrailing12Months§3.3608956
currency§USD
dateShortInterest§1702598400
forwardEps§-2.04
exchange§NCM
quoteType§EQUITY
shortName§DermTech, Inc.
longName§DermTech, Inc.
firstTradeDateEpochUtc§1502371800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§3c8d4862-51af-3b8e-b9ac-a8b0d23d08ec
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.5
targetLowPrice§2.5
targetMeanPrice§3.6
targetMedianPrice§4.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§5.683
grossMargins§-0.036199998
ebitdaMargins§0.0
trailingPegRatio§None
